Evidence map›Paper›PMID 25903363›Full record

ArticleMolecules (Basel, Switzerland)2015

Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3.

Mark Wolfenden, Jonathan Cousin, Pratima Nangia-Makker, Avraham Raz, Mary Cloninger

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Quantification of binding affinity of glyconanomaterials with lectins.Chemical communications (Cambridge, England) · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mark WolfendenDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA. mlwolfenden@gmail.com.
Jonathan CousinDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA. jon.cousin@chemistry.montana.edu.
Pratima Nangia-MakkerThe Departments of Oncology and Pathology, School of Medicine, Wayne State University, Detroit, MI 48201, USA. makkerp@karmanos.org.
Avraham RazThe Departments of Oncology and Pathology, School of Medicine, Wayne State University, Detroit, MI 48201, USA. raza@karmanos.org.
Mary CloningerDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA. mcloninger@chemistry.montana.edu.
Montana State University · USWayne State University · US

Funding

Using Dendrimers to Design Multivalent Therapeutic AgentsR01GM062444 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI CLONINGER, MARY J · 2001 to 2015
$3.5M
NIGMS NIH HHS GM62444NIGMS NIH HHS R01 GM062444
6 · The paper itself

Abstract

Multivalent protein-carbohydrate interactions that are mediated by sugar-binding proteins, i.e., lectins, have been implicated in a myriad of intercellular recognition processes associated with tumor progression such as galectin-mediated cancer cellular migration/metastatic processes. Here, using a modified ELISA, we show that glycodendrimers bearing mixtures of galactosides, lactosides, and N-acetylgalactosaminosides, galectin-3 ligands, multivalently affect galectin-3 functions. We further demonstrate that lactose functionalized glycodendrimers multivalently bind a different member of the galectin family, i.e., galectin-1. In a modified ELISA, galectin-3 recruitment by glycodendrimers was shown to directly depend on the ratio of low to high affinity ligands on the dendrimers, with lactose-functionalized dendrimers having the highest activity and also binding well to galectin-1. The results depicted here indicate that synthetic multivalent systems and upfront assay formats will improve the understanding of the multivalent function of galectins during multivalent protein carbohydrate recognition/interaction.

Indexed as

Binding SitesDendrimersEnzyme-Linked Immunosorbent AssayGalectin 1Galectin 3GlycosidesHumansProtein BindingDendrimersGalectin 1Galectin 3Glycosides

Identifiers

PMID25903363
PMCPMC4513649
OpenAlexW2054907482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.